We are live on
!
Find out more
ACM
Atika Capital Management Portfolio holdings
AUM
$796M
1-Year Est. Return
167.57%
This Fund
S&P 500
This Quarter
Est. Return
+23.47%
1 Year Est. Return
+167.57%
3 Year Est. Return
+553.47%
5 Year Est. Return
+1,283.26%
10 Year Est. Return
+44,203.78%
AUM
$558M
AUM Growth
+$37.6M
(+7.2%)
Cap. Flow
-$24.1M
Cap. Flow
% of AUM
-4.32%
Top 10 Holdings %
Top 10 Hldgs %
33.83%
Holding
112
New
24
Increased
27
Reduced
29
Closed
27
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Elevance Health
ELV
|
+$6.49M |
| 2 |
Molina Healthcare
MOH
|
+$6.13M |
| 3 |
Centene
CNC
|
+$5.55M |
| 4 |
DexCom
DXCM
|
+$5.21M |
| 5 |
Bio-Rad Laboratories Class A
BIO
|
+$5.12M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
WW
WW International
WW
|
+$12.1M |
| 2 |
Etsy
ETSY
|
+$6.63M |
| 3 |
Autodesk
ADSK
|
+$5.08M |
| 4 |
Meta Platforms (Facebook)
META
|
+$4.16M |
| 5 |
PTLA
Portola Pharmaceuticals, Inc.
PTLA
|
+$4.15M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 36.91% |
| 2 | Technology | 14.91% |
| 3 | Communication Services | 9.68% |
| 4 | Consumer Discretionary | 8.3% |
| 5 | Materials | 2.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
PUT
iShares Russell 2000 ETF
IWM
$80.9B
| $42.1M | 7.56% |
+250,000
| New | +$42.2M |
|
2
PUT
Invesco QQQ Trust
QQQ
$455B
| $27.9M | 5% |
150,000
-300,000
| -67% | -$54.3M |
|
3
PUT
State Street SPDR S&P Biotech ETF
XBI
$10.1B
| $24M | 4.3% |
250,000
+50,000
| +25% | +$4.85M |
|
|
4
DexCom
DXCM
$27.6B
| $16.7M | 3% |
468,000
+168,000
| +56% | +$5.21M |
|
|
WWE
5
CALL
DELISTED
World Wrestling Entertainment
WWE
| $15M | 2.69% |
155,000
| – | – |
|
6
CALL
LivaNova
LIVN
$4.3B
| $14.6M | 2.61% |
+117,500
| New | +$13.9M |
|
7
Sarepta Therapeutics
SRPT
$1.66B
| $12.8M | 2.29% |
79,000
+7,000
| +10% | +$957K |
|
8
Atlanta Braves Holdings Series B
BATRK
$3.23B
| $12.2M | 2.2% |
449,456
-9,900
| -2% | -$258K |
|
9
Netflix
NFLX
$292B
| $11.9M | 2.13% |
318,000
-7,000
| -2% | -$254K |
|
10
Teladoc Health
TDOC
$1.58B
| $11.5M | 2.06% |
133,000
+54,000
| +68% | +$3.85M |
|
11
Microsoft
MSFT
$2.84T
| $11.3M | 2.03% |
99,000
+9,000
| +10% | +$976K |
|
12
Amazon
AMZN
$2.5T
| $11.3M | 2.03% |
113,000
-2,000
| -2% | -$188K |
|
13
Intuitive Surgical
ISRG
$121B
| $11.1M | 1.99% |
57,900
+3,900
| +7% | +$693K |
|
|
XYZ
14
Block Inc
XYZ
$45.9B
| $10.4M | 1.86% |
105,000
+15,000
| +17% | +$1.16M |
|
15
NovoCure
NVCR
$2.04B
| $10.3M | 1.85% |
197,000
+107,000
| +119% | +$4.26M |
|
|
EXAS
16
DELISTED
Exact Sciences
EXAS
| $9.87M | 1.77% |
125,000
+7,000
| +6% | +$456K |
|
17
Okta
OKTA
$24.1B
| $9.71M | 1.74% |
138,000
+15,000
| +12% | +$893K |
|
18
RingCentral
RNG
$4.05B
| $9.21M | 1.65% |
99,000
-9,000
| -8% | -$777K |
|
19
HubSpot
HUBS
$10.5B
| $9.06M | 1.62% |
60,000
-5,500
| -8% | -$756K |
|
20
Roku
ROKU
$21.1B
| $8.33M | 1.49% |
114,000
-46,000
| -29% | -$2.63M |
|
|
ARNA
21
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $8.28M | 1.49% |
180,000
-10,000
| -5% | -$405K |
|
22
UnitedHealth
UNH
$382B
| $7.93M | 1.42% |
29,800
+1,300
| +5% | +$338K |
|
23
Align Technology
ALGN
$12B
| $7.82M | 1.4% |
20,000
-7,000
| -26% | -$2.58M |
|
|
LKFT
24
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.82B
| $7.32M | 1.31% |
65,100
+6,100
| +10% | +$644K |
|
|
25
Molina Healthcare
MOH
$10.3B
| $7.14M | 1.28% |
+48,000
| New | +$6.13M |
|
Similar funds
AGA
ATS
RIM
ACM
CAM
LSA
GWA
Atika Capital Management's Q3 2018 Portfolio in Review
As of Q3 2018, Atika Capital Management held 112 positions worth $558M, up 7.2% from $520M the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Atika Capital Management withdrew a net $24.1M in Q3 2018, closing 27 positions and reducing 29 holdings. Its most notable exit was WW International, an estimated $12.1M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 37% of assets, up from 26% a quarter earlier, followed by Technology and Communication Services.
Against the trend, Atika Capital Management opened a new position in Elevance Health worth $6.85M.
- Atika Capital Management's largest Q3 2018 buy was Elevance Health: 25,000 shares worth $6.85M.
- Atika Capital Management added most to DexCom in Q3 2018, an estimated $5.21M increase.
- Atika Capital Management's biggest Q3 2018 reduction was Etsy, cutting an estimated $6.63M.
- Atika Capital Management fully exited WW International in Q3 2018, selling an estimated $12.1M.
- Atika Capital Management's ten largest holdings make up 34% of its $558M portfolio in Q3 2018.
- Atika Capital Management opened 24 new positions and closed 27 in Q3 2018.
- Atika Capital Management's portfolio value rose 7.2% quarter-over-quarter to $558M.
Based on Atika Capital Management's 13F filing for Q3 2018, filed 14 Nov 2018.